Telix Pharmaceuticals Ltd
ASX:TLX
Cash Flow Statement
Cash Flow Statement
Telix Pharmaceuticals Ltd
Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
(2)
|
(8)
|
(10)
|
(11)
|
|
Cash Interest Paid |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
|
Change in Working Capital |
9
|
11
|
11
|
12
|
31
|
19
|
1
|
(15)
|
(14)
|
|
Cash from Operating Activities |
(27)
N/A
|
2
N/A
|
(8)
N/A
|
(59)
-622%
|
(91)
-53%
|
(64)
+30%
|
10
N/A
|
24
+151%
|
50
+108%
|
|
Investing Cash Flow | ||||||||||
Capital Expenditures |
(1)
|
(0)
|
(0)
|
(1)
|
(10)
|
(14)
|
(8)
|
(11)
|
(28)
|
|
Other Items |
(0)
|
(1)
|
(1)
|
(1)
|
(3)
|
(3)
|
(1)
|
(15)
|
(40)
|
|
Cash from Investing Activities |
(1)
N/A
|
(1)
-9%
|
(1)
-12%
|
(3)
-123%
|
(13)
-387%
|
(17)
-28%
|
(9)
+50%
|
(25)
-198%
|
(68)
-169%
|
|
Financing Cash Flow | ||||||||||
Net Issuance of Common Stock |
46
|
35
|
36
|
4
|
182
|
181
|
5
|
7
|
4
|
|
Net Issuance of Debt |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
2
|
4
|
4
|
3
|
|
Other |
0
|
(0)
|
0
|
0
|
(8)
|
(8)
|
0
|
0
|
0
|
|
Cash from Financing Activities |
44
N/A
|
34
-22%
|
34
0%
|
3
-92%
|
174
+6 003%
|
175
+1%
|
8
-95%
|
10
+20%
|
8
-25%
|
|
Change in Cash | ||||||||||
Effect of Foreign Exchange Rates |
(2)
|
(2)
|
1
|
3
|
3
|
0
|
(0)
|
(2)
|
(2)
|
|
Net Change in Cash |
14
N/A
|
33
+134%
|
25
-24%
|
(56)
N/A
|
73
N/A
|
94
+29%
|
9
-90%
|
7
-24%
|
(13)
N/A
|
|
Free Cash Flow | ||||||||||
Free Cash Flow |
(27)
N/A
|
2
N/A
|
(9)
N/A
|
(61)
-600%
|
(101)
-67%
|
(78)
+23%
|
2
N/A
|
13
+613%
|
21
+63%
|